Schizophrenia 9

Common Name(s)

Schizophrenia 9

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Schizophrenia 9" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Schizophrenia 9" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Schizophrenia 9" returned 14 free, full-text research articles on human participants. First 3 results:

Regulators of G-protein signaling 9 genetic variations in Chinese subjects with schizophrenia.
 

Author(s): Y S Zhu, Y X Li, X M Qiao, H B Zhang

Journal:

 

To identify single-nucleotide polymorphisms that contribute to the genetic susceptibility to schizophrenia, we examined the potential association between schizophrenia and 9 single nucleotide polymorphisms (rs1530351, rs4791230, rs2869577, rs8077696, rs8070231, rs2292592, rs9916525, ...

Last Updated: 8 Sep 2015

Go To URL
The 4th Schizophrenia International Research Society Conference, 5-9 April 2014, Florence, Italy: a summary of topics and trends.
 

Author(s): Olukayode Abayomi, Davide Amato, Candace Bailey, Byron Bitanihirwe, Lynneice Bowen, Shimon Burshtein, Alexis Cullen, Montserrat Fusté, Ana P Herrmann, Babak Khodaie, Sanja Kilian, Qortni A Lang, Elizabeth E Manning, Raffael Massuda, Milawaty Nurjono, Sarosh Sadiq, Teresa Sanchez-Gutierrez, Tamara Sheinbaum, Venkataram Shivakumar, Nicholas Simon, Anneliese Spiteri-Staines, Suttajit Sirijit, Nanna Gilliam Toftdahl, Sunali Wadehra, Yi Wang, Rebekah Wigton, Susan Wright, Sergey Yagoda, Yuliya Zaytseva, Anne O'Shea, Lynn E DeLisi

Journal: Schizophr. Res.. 2014 Nov;159(2-3):e1-22.

 

The 4th Schizophrenia International Research Society Conference was held in Florence, Italy, April 5-9, 2014 and this year had as its emphasis, "Fostering Collaboration in Schizophrenia Research". Student travel awardees served as rapporteurs for each oral session, summarized the ...

Last Updated: 3 Dec 2014

Go To URL
Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine.
 

Author(s): Hidenaga Yamamori, Ryota Hashimoto, Tamaki Ishima, Fukuko Kishi, Yuka Yasuda, Kazutaka Ohi, Michiko Fujimoto, Satomi Umeda-Yano, Akira Ito, Kenji Hashimoto, Masatoshi Takeda

Journal: Neurosci. Lett.. 2013 Nov;556():37-41.

 

Brain-derived neurotrophic factor (BDNF) regulates the survival and growth of neurons, and influences synaptic efficiency and plasticity. Peripheral BDNF levels in patients with schizophrenia have been widely reported in the literature. However, it is still controversial whether peripheral ...

Last Updated: 25 Nov 2013

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Schizophrenia 9" returned 1 free, full-text review articles on human participants. First 3 results:

Matrix Metalloproteinase-9 as a Novel Player in Synaptic Plasticity and Schizophrenia.
 

Author(s): Katarzyna Lepeta, Leszek Kaczmarek

Journal: Schizophr Bull. 2015 Sep;41(5):1003-9.

 

Recent findings implicate alterations in glutamate signaling, leading to aberrant synaptic plasticity, in schizophrenia. Matrix metalloproteinase-9 (MMP-9) has been shown to regulate glutamate receptors, be regulated by glutamate at excitatory synapses, and modulate physiological ...

Last Updated: 14 Aug 2015

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

There are currently no open clinical trials for this condition.